View Older Stories View More Recent Stories

Jan 19, 2025 07:53AM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 17, 2025 08:45PM AZN INVESTOR ALERT: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Jan 17, 2025 05:03PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 17, 2025 07:16AM AstraZeneca (AZN:LN) (AZN) PT Raised to GBP13,100 at Guggenheim
Jan 17, 2025 07:00AM AstraZeneca (AZN) Reports CALQUENCE plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma
Jan 16, 2025 04:58PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 15, 2025 04:53PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 14, 2025 04:48PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 14, 2025 04:23PM AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption - Hagens Berman
Jan 13, 2025 04:47PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 13, 2025 06:09AM AstraZeneca (AZN) Reports Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Jan 12, 2025 04:47PM ROSEN, A HIGHLY-REGARDED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 12, 2025 09:14AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 11, 2025 04:47PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 9, 2025 10:45PM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 9, 2025 07:11PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 8, 2025 07:06PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 7, 2025 07:05PM ROSEN, A LONGSTANDING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 7, 2025 11:00AM TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'
Jan 5, 2025 10:06PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 5, 2025 09:50AM AZN INVESTOR ALERT: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 4, 2025 10:05PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 4, 2025 12:45PM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 3, 2025 10:05PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 3, 2025 07:18AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Jan 2, 2025 10:04PM ROSEN, A RANKED AND LEADING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 2, 2025 04:00PM AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 2, 2025 12:48PM AstraZeneca (AZN) Reels from China Investigation and Investor Suit- Hagens Berman
Jan 2, 2025 12:39PM TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
Jan 1, 2025 10:03PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 1, 2025 11:06AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Dec 31, 2024 10:03PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 30, 2024 10:02PM ROSEN, A TOP-RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 29, 2024 10:01PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 28, 2024 10:00PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 27, 2024 09:59PM ROSEN, A TOP-RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 26, 2024 09:56PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 25, 2024 09:55PM ROSEN, LEADING INVESTOR COUNSEL Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 25, 2024 04:00PM AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Dec 24, 2024 09:54PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 24, 2024 09:30AM Achilles Therapeutics (ACHL) Sells Technology Assets to AstraZeneca (AZN)
Dec 24, 2024 06:58AM AstraZeneca (AZN) reports Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn
Dec 23, 2024 03:30PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 23, 2024 02:56PM AstraZeneca (AZN) call put ratio 1 call to 1.7 puts as share price up 1.5%
Dec 23, 2024 06:29AM AstraZeneca's (AZN) Tagrisso approved in the EU for patients with unresectable EGFR-mutated lung cancer
Dec 20, 2024 10:59PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
Dec 19, 2024 07:51PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
Dec 18, 2024 04:54PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
Dec 12, 2024 02:00PM Tracer Biotechnologies Announces Agreement with AstraZeneca (AZN) for Next-Generation Cancer Monitoring for Drug Development
Dec 11, 2024 09:44AM Truist: 'Potential Impact of Trump's Nominees on Biopharma'
View More Recent Stories View Older Stories